E7080, a Multi–Tyrosine Kinase Inhibitor, Suppresses the Progression of Malignant Pleural Mesothelioma with Different Proangiogenic Cytokine Production Profiles
Kenji Ikuta(Nagoya City University), Saburo Sone(Io Therapeutics (United States)), Yasuhiko Nishioka(Tokushima University), Yoshitaka Sekido(Aichi Cancer Center), Hisanori Uehara(Tokushima University Hospital), Hisatsugu Goto(Tokushima University), Toshimitsu Uenaka(Kanazawa University), Van The Trung(Kanazawa University), Tadaaki Yamada(Kyoto Prefectural University of Medicine), Qi Li(Qingdao National Laboratory for Marine Science and Technology), Wei Wang(Nanfang Hospital), Masaki Hanibuchi(Tokushima University), Soji Kakiuchi(Tokushima Prefectural Central Hospital), Hirokazu Ogino(Tokushima University), Seiji Yano(Kanazawa University Hospital)
Cited by 72
Related Papers
Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China
|New England Journal of Medicine|2013|698
Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
|Cancer Research|2008|642
Integrative Molecular Characterization of Malignant Pleural Mesothelioma
|Cancer Discovery|2018|630
Birth Weight Reference Percentiles for Chinese
|PLoS ONE|2014|369
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells
|Nature Communications|2019|360